According to our knowledge, this is the fi rst research experiment that focuses on the study of the distribution of c-kit positive cells at the sites of myocardial infarction in human hearts (Fig. 3, Ref. 16 ). Text in PDF www.elis.sk.
The human body consists of approximately 200 types of morphologically and functionally different cells. The number of different types of cells will be probably never known exactly, because some cells may be in different stages of development. Only a few years ago, a research team led by professor Laurentiu Popescu from Bucharest, Romania described a completely new cell population. These newly discovered cells were fi rst referred to as interstitial Cajal-like cells. This name was refl ecting their apparent resemblance to the interstitial cells of Cajal, pacemaker cells in the wall of gut observed by Santiago Ramón y Cajal more than 100 years ago. As further studies gradually exposed their unique ultrastructure and immunophenotype, it became obvious, that interstitial Cajal-like cells are different from gastrointestinal interstitial cells of Cajal. Therefore, it was proposed to call these new cells telocytes (1) .
Very interesting is to study the functional roles of telocytes in different organs, especially from the point of view of regenerative medicine. The question of telocytes is one of the most attractive questions in histology and regenerative medicine in the last fi ve years. The processes of regeneration and reparation in the heart, the most important vital organ of the human body, are not only fascinating from the scientifi c point of view, but are also clinically very important. For this reason the article entitled "A comprehensive guide to telocytes and their great potential in cardiovascular system", published by the Bratislava Medical Journal (2) has brought us an optimistic expectations, that telocytes will make the myocardial regeneration possible in near future. We share, in our recently published article (3), some of the cited authors´ view especially on the role of cardiac telocytes as the key cell population responsible for the maintenance of the cardiac microenvironment homeostasis, by the means of functional interconnection and integration of a wide variety of cell types within the heart (cells of immune system, endothelial cells, cardiomyocytes, stem cells, etc.). However, we do not support the confi dence of data about molecular biology, morphology, and pathophysiology of telocytes published by Kucybala et al (2) because of very simplistic and unadvised presentation. Application of results from experimental studies into clinical practice has to be very careful and responsible.
It is necessary to point out, that there is an ongoing wide dispute among histologists, pathologists and cell biologists about the nature of telocytes as a distinct and unique cell population. One of the principal opinions, opposing their status as an individual cell type, is that they represent "only" a highly specialized population/subtype of fi broblasts, endothelial cells, or immunological stem cells. Because of such arguments a broad consensus is still kept out of reach. It has not been changed even by the fact, that PubMed database reads more than 240 publications after key word "telocytes" is typed into the search box and more than 50 % of the results are from the last three years. Aforementioned discrepancy is well documented in the works of Díaz-Flores et al (4) , who termed this cell population as "CD34+ stromal fi broblastic cells," Ivey and Tallquist (5) who used "cardiac telocyte" as a synonymic term for "cardiac fi broblast", but also in the newest hypothesis published by Rusu et al (6) who described some subsets of cardiac telocytes as cells belonging to endothelial lineage.
The processes of regeneration and reparation after injuries and during chronic diseases modify tissue architecture by a sequential orchestration of events including cell proliferation, differentiation, dedifferentiation and cell apoptosis or necrosis (7) . During evaluation of the results focused on the role of telocytes, it has to be clearly stated which results were achieved from experimental, animal and human studies. This is also a problem of Kucybala´s et al review (2) . It is very hopeful that some recently published studies investigated changes in the distribution and function of telocytes associated with cardiovascular disease. But most of them are based on experiments on rats (8-10) and only one paper is focused on the investigation of human end-stage failing hearts (11) . However, to describe cardiac telocytes as having therapeutic potential for humans inappropriate at this stage of research, because there are too many controversies. The same applies to cardiac telocytes experimental transplantation in animal models which signifi cantly increase vessel density and decrease myocardial fi brosis at the heart infarction site (9) . Up to now, the distribution of telocytes within the infarction site and scar tissue in the human heart is still unknown. 
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Our preliminary study was focused on the immunohistochemical detection of telocytes at the site of acute myocardial infarction, as well as at different times after the infarction. Myocardial tissue was obtained during necropsies of a group consisting of 20 human hearts (mean age 70.9 ± 11.2). The immunohistochemical characterization of human cardiac telocytes was performed using a c-kit (CD117) antibody (Dako, Denmark). However, it has to be mentioned that antibodies against c-kit (CD117) are not telocyte-specifi c, they label the transmembrane tyrosine kinase receptor located on the surface of wide variety of cells (e.g. stem cells and mast cells). Primary antibodies were used according to the manufacturer's protocols. For visualization, we used EnVision™ FLEX Detection system (HRP SM802, Dako, Denmark) with diaminobenzidine as a chromogen. Cell nuclei were stained with Mayer's hematoxylin. Our preliminary results are represented by the photomicrographs 1-3. Cells, positive for c-kit, probably telocytes, were not detected at the site of acute myocardial infarction (Fig. 1) . We assume that they perished as a result of the infarction development, since telocytes are typically found at the sites of the myocardium unaffected by necrosis. In contrast with the aforementioned experiments on rats, the number of c-kit positive spindle-shaped telocytes in human myocardium from patients who have overcame the heart attack, varies signifi cantly. In some cases, we truly found a higher number of telocytes inside myocardium nearby the site of connective tissue scars ( Fig. 2 and 3) , while in other cases, we couldn´t detect almost none of these cells.
However, it´s important to note, that the research of telocytes in human hearts is markedly different from the research layout in animal models. Firstly, the human patient age, as the main contributor to diminished regenerative capacity of the whole organism, is relatively higher. Furthermore, the infarction sites are localized in various areas within the heart. This situation is in a sharp contrast to what can be achieved in rats -the rat model with a surgically induced infarction by the means of ligation of the left anterior descending coronary artery, creates the possibility to target the same specifi c selected part of the myocardium. Moreover, the treatment of the patients with the acute myocardial infarction is not always the same, as different drugs affecting the heart and metabolism are often used. It is also necessary to point out, that elderly patients usually suffer from multiple comorbidities. All these unstable factors in humans may infl uence the morphology of cardiovascular system. In spite of the mentioned variables, we still agree, that the observations in animal models may suggest that telocytes play an important role in the regeneration/reparation of the myocardium, or in the neoangiogenesis at the sites affected by myocardial infarction. We do not like to degrade their importance. On the other hand, we must emphasize, that the further research into the role of telocytes in similar reparative mechanisms within the human myocardium, is still necessary.
According to our knowledge, this is the fi rst research experiment that focuses on the study of the distribution of c-kit positive cells at the sites of myocardial infarction in human hearts. The pathophysiological consequences of altered telocytes´ number in many heart diseases are largely unknown (12) . On the other hand, the role of cardiac telocytes as progenitor cells and / or "nurse cells" (supporting cells) in the human endocardial stem cell niches were described in numerous studies (13, 14) . We incline to the hypothesis of other authors that, in the future, telocytes might have a huge therapeutic potential for the design of some future cell-based cardiac regeneration, repair and protection strategies (15, 16) . But the way from experimental animal studies to clinically important results, which may directly improve the quality of life of patients with different acute and chronic cardiac diseases, is extremely long and demanding.
